首页 › 基金 › Palo Alto Investors LP › BNTX
Palo Alto Investors LP 对 BNTX 的持仓历史
BIONTECH SE · 医疗保健
Palo Alto Investors LP 在 Q3 2026 的 13F 申报中披露持有 BNTX(BIONTECH SE)19,614 股,市值约 US$1.9M,约占其申报组合的 0.29%,在其申报持仓中市值排名第 42 位。 Palo Alto Investors LP 最近 9 个申报季度中有 9 个季度披露了 BNTX 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Palo Alto Investors LP 对 BNTX 的持仓演变
Palo Alto Investors LP 于 Q3 2024 首次披露 BNTX 持仓:25,206 股(约 US$3.0M)。 在 9 次申报中,Palo Alto Investors LP 0 次增持、1 次减持、7 次保持不变。 最近一期申报(Q3 2026)显示持股 19,614 股、市值约 US$1.9M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 25.21K | $2.99M | 新进 |
| Q4 2024 | 25.21K | $2.87M | 持有 |
| Q1 2025 | 25.21K | $2.30M | 持有 |
| Q2 2025 | 25.21K | $2.68M | 持有 |
| Q3 2025 | 19.61K | $1.93M | 减持 |
| Q4 2025 | 19.61K | $1.87M | 持有 |
| Q1 2026 | 19.61K | $1.74M | 持有 |
| Q2 2026 | 19.61K | $1.83M | 持有 |
| Q3 2026 | 19.61K | $1.93M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BNTX 与 13F 数据
BNTX(BIONTECH SE)属于医疗保健行业。我们追踪的基金中还有 30 只申报持有 BNTX,申报仓位最大的包括:Davern Capital Partners, LP (US$67.1M), GSK plc (US$65.7M), Logos Global Management LP (US$63.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BNTX 的基金
- Davern Capital Partners, LP 682.15K 股 · $67.06M · Q3 2026
- GSK plc 668.53K 股 · $65.72M · Q3 2026
- Logos Global Management LP 650.00K 股 · $63.90M · Q3 2026
- Long Focus Capital Management, LLC 632.00K 股 · $62.13M · Q3 2026
- SAMLYN CAPITAL, LLC 561.70K 股 · $55.21M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K 股 · $46.20M · Q3 2026
更多关于 Palo Alto Investors LP
常见问题
How long has Palo Alto Investors LP held BNTX?
Palo Alto Investors LP has disclosed BNTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Palo Alto Investors LP's current position in BNTX?
As of Q3 2026, Palo Alto Investors LP holds 19.61K shares of BNTX (BIONTECH SE), valued at $1.93M, representing 0.29% of its reported portfolio and ranking #42.
Has Palo Alto Investors LP been buying or selling BNTX?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in BNTX.
Which other funds hold BNTX?
Other major institutional holders of BNTX include Davern Capital Partners, LP, GSK plc, Logos Global Management LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.